Your Exclusive Returning Customer Monjaro Prices
Automatic £25 Savings on Every Monjaro Order
As a returning EverydayMeds customer, you automatically receive £25 off every Monjaro purchase. Your 2.5mg pen costs just £144.99 instead of £169.99. Need 5mg strength? Pay only £174.99 rather than £199.99. Higher doses offer the same savings - 10mg pens at £244.99 and 15mg at £293.99. This isn't a one-time offer - these discounted prices apply to every single reorder you make.
Streamlined Reordering Process
Your previous clinical assessment means faster approval for continuing treatment. Standard processing takes just 3 working days, or upgrade to express 24-hour service. We have your medical history on file, making reorders smooth and efficient. Simply select your required strength and quantity - your prescription-only Monjaro will be dispatched promptly to maintain your treatment schedule.
All Monjaro Strengths Available
Whether you're progressing through dose escalation or maintaining your optimal strength, all Monjaro doses are in stock. Start at 2.5mg for £144.99, progress to 7.5mg at £224.99, or continue with maintenance doses up to 15mg. Multi-pen bundles also qualify for returning customer discounts - Progress Duo (5mg + 7.5mg) saves you money on combination orders for smooth dose transitions.
Loyalty Benefits That Continue
Your returning customer status means priority processing and dedicated support. Questions about your Monjaro prescription? Our pharmacy team prioritises existing customers. Need to adjust your order or change delivery? Your account history makes modifications straightforward. These benefits compound with every order - the more you reorder, the smoother the process becomes.
Order Your Monjaro Continuation Today
Don't let your treatment lapse. Your prescription-only tirzepatide therapy works best with consistent dosing alongside your reduced-calorie diet and increased physical activity. Log into your account, select your required strength, and checkout with automatic £25 savings applied. Your continued commitment to treatment deserves these ongoing savings.
